Trending...
- CRG Awarded NASA SEWP VI Contracts in Categories B and C
- Salestrics Releases Version 2.0 to Unify CRM, Business Email, and Operations on a Single Customer Graph
- What's New in Hokkaido, Autumn 2026
Gov. Tom Wolf today issued the following statement on the Pennsylvania Supreme Court ruling upholding the constitutionality of Act 77 of 2019, the state's no-excuse mail-in voting law.
"Today's court ruling definitively asserts that mail-in voting is a legal and constitutional method for Pennsylvania voters. By upholding the law, which the General Assembly approved in 2019 in a bipartisan manner, this ruling assures that mail-in voting remains in place and Pennsylvanians will be able to cast their ballot legally in person or by mail without any disruption or confusion.
More on The PennZone
"Voting is a fundamental right — a right that we should ensure is accessible for all voters. Mail-in voting is a safe, secure and legal option for Pennsylvania voters to exercise that right. I will continue to advocate for voting reforms that remove barriers and increase access to voting."
SHARE Email Facebook Twitter
"Today's court ruling definitively asserts that mail-in voting is a legal and constitutional method for Pennsylvania voters. By upholding the law, which the General Assembly approved in 2019 in a bipartisan manner, this ruling assures that mail-in voting remains in place and Pennsylvanians will be able to cast their ballot legally in person or by mail without any disruption or confusion.
More on The PennZone
- WebDrafter Highlights How AI Search Is Reshaping Online Visibility
- Socialhose Eyes Southeast Asia and Rejects the Copy-Paste Expansion Playbook
- $40 Billion Global Market Value by 2030 Projected in Unmanned Aerial Vehicle or Other Drone Technology Sector, Growing at 9.2% Compound Annual Growth
- A.M. Logging Returns to Ag Progress Days for Eighth Year
- $620 Million in Recent Government Contract Awards with More Than $1.2 Billion in Annualized Revenue: Circle8 Group (N A S D A Q: CIRC)
"Voting is a fundamental right — a right that we should ensure is accessible for all voters. Mail-in voting is a safe, secure and legal option for Pennsylvania voters to exercise that right. I will continue to advocate for voting reforms that remove barriers and increase access to voting."
SHARE Email Facebook Twitter
0 Comments
Latest on The PennZone
- Brother Marcus Unlocks the Vault
- L2 Aviation Selected for U.S. Air Force KC-46 CASPER Multiple Award Contract
- Leeds Billboard Campaign Drives 188% Traffic Uplift as AI Enquiries Rise 266% for Loud! OOH
- Sister Files Lawsuit Against Georgia Funeral Home for Alleged Mishandling of Brother's Remains
- KeysCaribbean Resorts Offer Savings On Summer Vacations Now Through Aug. 31
- Crossroads4Hope Announces The Lipschutz Women's Fund
- AI, Drones, Defense & Explosive Growth: Why ZenaTech Is Emerging as One of the Most Compelling Technology Growth Stories (N A S D A Q: ZENA)
- 91 Per Cent of Enterprises Will Increase AI Spending. Most Can't See the Cost — or the Risk!
- Harrisburg's newest restaurant, Eleve, sells out entire inventory during Grand Opening
- New ProEssentials v11: Native WinUI Charting Library, 100M Points in 15ms, Following Microsoft's Vision for True Native Swap-Chain Rendering
- New AI Customer Segmentation Guide Warns Marketers Not to Confuse Technical Precision With Business Value
- Salestrics Releases Version 2.0 to Unify CRM, Business Email, and Operations on a Single Customer Graph
- Aderra Opens in Magnolia, Texas, Offering a New Model for 62+ Homeownership
- What's New in Hokkaido, Autumn 2026
- CRG Awarded NASA SEWP VI Contracts in Categories B and C
- Heidi G. Villari of The Villari Firm, PLLC Named to Super Lawyers for the Tenth Consecutive Year
- Elevate Your Sneakers With Crep Protect Trek Laces
- Meet Privateer: Tucson's High-Tech Security Force Built With Paramilitary Precision
- Dynamic Dachshund Dog Goes Global: Remember Point Launches a New Bilingual Children's Book
- DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care